Pharmafile Logo
Pharmafocus logo
Advanced Search

brintellix

Showing 3 posts of 3 posts found.

brintellix

FDA issues CRL for Takeda/Lundbeck’s Brintellix

March 29, 2016
Manufacturing and Production, Research and Development Lundbeck, Takeda, brintellix

Takeda and Lundbeck have received a complete response letter from the US Food and Drug Administration (FDA) for the supplemental …

News
Lundbeck HQ

Lundbeck gets go-ahead for US and EU licence expansions

February 4, 2016
Medical Communications, Sales and Marketing Abilify, EMA, FDA, Lundbeck, Otsuka, Takeda, aripiprazole, brintellix, vortioxetine

Lundbeck has earned two recommendations from regulatory committees of the FDA and the EMA, which both recommended the company’s drugs …

News
Lundbeck image

Brintellix ‘yes’ from FDA

October 4, 2013
Sales and Marketing FDA, Lundbeck, Takeda, brintellix

Takeda Pharmaceutical Company and Lundbeck are celebrating after the FDA approved their depression treatment Brintellix – despite there being no …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025